Because SRNS cause ∼15% of all CKD in the first two decades of life6, the balance of RAC1/CDC42 signalling may be a worthwhile target when developing drugs to prevent ESKD that is caused by SRNS. Here, RAC1 is linked to chronic kidney disease.